Ignite Creation Date:
2024-05-05 @ 6:36 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00516945
Status:
COMPLETED
Last Update Posted:
2013-09-05
First Post:
2007-08-15
Brief Title:
A Study to Investigate Whether the Immediate Use or Deferred Use of an Anti-viral Drug Lamivudine Will Help to Better Safe-guard the Delivery of Chemotherapy in Patients With Cancer Who Are Also Hepatitis B Carriers
Sponsor:
Hospital Authority Hong Kong
Organization:
Hospital Authority Hong Kong
Organization Data
Organization:
Hospital Authority Hong Kong
Class:
OTHER_GOV
Study ID:
KCKE04-0046FR-2
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Hospital Authority Hong Kong
Lead Sponsor Class:
OTHER_GOV
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None